AGRX - Agile Therapeutics regains compliance with Nasdaq minimum bid price requirement
2023-04-26 09:06:41 ET
- Agile Therapeutics ( NASDAQ: AGRX ) has received a notification letter from the Nasdaq, informing the Co. that it has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule.
- On April 25, 2023, Nasdaq provided confirmation to the Co. that for the last 10 consecutive business days, from April 11, 2023 to April 24, 2023, the closing bid price of the Co.’s common stock has been at $1 or greater.
For further details see:
Agile Therapeutics regains compliance with Nasdaq minimum bid price requirement